Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Jiong-Wei Wang

Jiong-Wei Wang

National University of Singapore Singapore

Eshu Middha

Eshu Middha

National University of Singapore Singapore

Muthu Kumara Gnanasammandhan Jayakumar

Muthu Kumara Gnanasammandhan Jayakumar

National University of Singapore Singapore

Kritika Khurana

Kritika Khurana


Neha Dikshit

Neha Dikshit

Duke-NUS Medical School, Singapore Singapore

Monika Mehta

Monika Mehta

National University of Singapore Singapore

More Vrunal

More Vrunal

Shri Vithal Education and Research Institutes College of Pharmacy India

Khushboo Tripathi

Khushboo Tripathi

PES University India

Pharma Biotech Congress 2019

About Conference

Conference series llc LTD proudly announces the commencement of “2ndAnnual Pharmaceutical Biotechnology Congress” which is going to be held during September 11-12, 2019 at Singapore.

Pharma Biotech Congress 2019 focuses upon “Comprehensive Innovations and Researches in Pharmaceutical Biotechnology”.  This Pharma Biotech Congress 2019 focuses on the trends which the biopharmaceutical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors and also pharmacovigilance including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects towards biosimilars and follow on biologics development and successful launching to the market.

Why to attend???

Join your peers around the world focused on learning about Biopharmaceutics,  Biotechnology, Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biotechnology community  Biopharma community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 2-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.

Target Audience:

  • Biopharma, Biotech, Pharma Industry CEO, Directors, R&D Researchers
  • Business Entrepreneurs, Training Institutes, Software developing companies,
  • Medical Devices Manufacturing Companies, CRO
  • Data Management, Clinical Trial Conducting Organizations and Companies
  • Students, Scientists, Researchers, and Faculty of Pharmaceutical Sciences
  • Universities, Medical Colleges, Researchers from Pharmaceutical background

Sessions & Tracks

2ndAnnual Pharmaceutical Biotechnology Congress

September 11-12, 2019 Singapore

Conference Series llc LTD invites all the participants from all over the world to attend 2ndAnnual Pharmaceutical Biotechnology Congress during September 11-12, 2019 Singapore which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Pharma Biotech Congress 2019 offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics  Cell Therapy, Biopharmaceutics, Drug deliveryBiotechnology, Gene Therapy, Therapeutic Biological Products, BABE, Biosimilars, Clinical TrailsDrug Discovery, current issues in Bioequivalence, Pharmaceutical Innovation in the 21st Century, new scientific approaches to international regulatory standards. Biopharmaceutical Companies & Market Analysis, The conference invites delegates from Biopharma companies, Pharmacists, Academicians, Clinicians, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects.

Track 1: Biopharmaceuticals

Biopharmaceutical is also called as a Biological or Biologic pharmaceutical medication item fabricated from organic sources through extraction. The advancement of a pharmaceutical medication normally takes a normal of 10 – 15 years. Such a large amount of exertion, time and cash, it is exceptionally urgent that the correct advancements and materials are received in the examination, improvement and assembling of the pharmaceuticalmedications, whole process incorporates pre-disclosure, pre-clinical trials, showcase dispatch to post promoting observing. The wellsprings of medication items incorporate peptides and proteins, including monoclonal antibodies and neutralizer pieces. From 2000 to 2006, biologics represented 33% of all New Active Substances that were pre propelled, and are reflected to the present advancement pipelines of the pharmaceutical business.

Track 2: Novel Approaches in Biopharmaceutics

Novel Approaches in biopharmaceutical Drug Designing and Development is an interdisciplinary research. Centering upon medication planning procedures, new medications advancements in synthetic and organic research. An accomplishment of definition relies on upon how effectively it makes the medication accessible at the site of activity, particularly in oral plans. Methods have regularly been utilized to expand disintegration rate of the medication. Important to enhance dissolvability of medication by different ways like salt development, co-dissolvability

Track 3: Nanoparticles in Biopharmaceuticals

Nanoparticles with the end goal of medication conveyance are characterized as submicron, which are small colloidal particles. Nanoparticles are strong colloidal lattice like particles which are made of polymers or lipids. For the most part directed by the intravenous course like parenteral they have been created for the focused on conveyance of helpful or imaging specialists. By methods for focused medication conveyance framework will be accomplished rapidly, to enhance the pharmacokinetic and pharmacodynamics movement of the drug. Over late years headway in nanoparticles tranquilize conveyance is broadly anticipated that would change the pharmaceutical and biotechnology ventures for a long time to come.

Track 4: Biotechnology in Health Care

Biotechnology is the utilization of living frameworks and creatures to make items, by any innovative applications to make or adjust items or procedures for particular utilize. Science and innovation have in the past assumed an indispensable part in enhancing general wellbeing. Today the commitment of science to enhance general wellbeing and lessen worldwide wellbeing incongruities is more apropos than any other time in recent memory. However the advantages of current medication still have not achieved a huge number of individuals in creating nations. The developing wellbeing variations between the creating and the created world call for critical activity from established researchers.

Track 5: Formulation of Biotech Products

Biotech medicate formulators have many worries to juggle in their work, starting with the physicochemical qualities of a dynamic particle and including the dependability, cost, and accessibility of logical techniques utilized as a part of detailing work .The results of biotechnology are proteins and peptides that are generally flimsy atoms contrasted with most natural pharmaceuticals. At last the protein is traded into its last arrangement dose frame where long haul strength is accomplished. These incorporate rankles, bottles, vials, ampules, syringes. Developing conveyance techniques and gadgets.

Track 6: Agriculture Biotechnology

Rural biotechnology is otherwise called agritech. Which including the utilization of logical instruments and systems, including hereditary designing, a surge in innovation brought about an expansion in horticultural biotechnologythrough the determination of qualities like expanded yield. Agriculturists have controlled plants and creatures through specific reproducing for a huge number of years with a specific end goal to make wanted characteristics. Horticultural Biotechnology has been utilized to enhance the healthful substance of an assortment of products with an end goal to address the issues of an expanding populace. Atomic diagnostics, immunizations, and tissue culture, to alter living life forms plants, creatures, and microorganisms resistance.

Track 7: Advances in Biotech Manufacturing

Biotechnology is the utilization of living frameworks and life forms to make items, by any innovative applications to change items or procedures for particular utilize. Biotechnology has applications in four noteworthy modern regions, including Health mind, Crop generation and horticulture, Industrial employments of harvests and different items and Environmental employments. Biotechnology has likewise prompted to the advancement of anti-infection agents. Yield of a generation procedure are an ideal opportunity to aggregate a coveted measure of biomass, the procedure term, and the particular profitability. By contrasting greatest cell densities and particular development rates of different expression frameworks, and extensively depicted logical methodologies and procedures to enhance have cell lines. Other than the quantitative assessment of current frameworks, the quality-deciding properties of a host cell line.

Track 8: Biotechnology and its Applications

Biotechnology it is a piece of science that arrangements with utilization of living frameworks, by applying any innovative applications. That utilizations natural frameworks, living life forms, or subsidiaries thereof, to make items or procedures for particular utilize. Utilizations of biotechnology for the most part centered around Agro concoction agribusiness, Organic farming, and yield based horticulture. Uses of Biotechnology in Food ProcessingEnvironmental Biotechnology Applications of Biotechnology in Medicine, Industrial Biotechnology.

Track 9: Biopharmaceutical Engineering

Pharmaceutical building is a piece of pharmaceutical science. Innovation which includes improvement and assembling of items, procedures, and parts in the pharmaceuticals business. The touchy advancement in the pharmaceutical business turned into the main thrust for our new Biopharmaceutical Engineering Program. The branch of biopharmaceuticals is quickly forming into upstream medication definitions and downstream plan handle, by utilizing biopharmaceutical designing standards.

Track 10: Chemical Biotechnology

Biotechnology is defined as the application of the life sciences to chemical synthesis. This is a study of direct production of specific chemicals via fermentation, such as lactic acid and citric acid, Now-a-days chemical biotechnology is increasing biotechnology’s contribution to the industries. Chemical biotechnology mainly includes in both chemical engineering and scientific principles. chemical engineers helps to design, production of microorganisms and enzymes to synthesize new drugs. Huge number of industries that depend on the synthesis and processing of chemicals and materials. Which mainly deals with the oil industries, pharmaceutical industries, environmental process. Chemical engineers enjoy increasing opportunities.

Track 11: Cancer Biology and Immunology

Cancer is a group of deadly diseases characterized by uncontrolled cell division leading to growth of abnormal tissue. it is also called as degeneration of one type of cell within an organism into something and Immunology is relating investigation of science that manages the entrenched framework and its immunologic capacities and immune reaction. It's tremendous field that develops the atomic capacity and auxiliary capability and association. The resistant framework has been separated into a considerable measure of embryonic, natural immune framework, spineless creatures. A gained or versatile entrenched framework. The research of communication between tumour cells and typical cell and discovery of influenced cells square measure been likewise determined.

Track 12: Industrial and Microbial Biotechnology

Modern microbiology or microbial biotechnology is the application. Which is use to the procedure of microorganisms or plant and creature cells to make valuable items. Since from old circumstances, microoraganisms have been used as Industrial biotechnology, there are colossal measure of microoraganisms which are utilized for bread and cakes, protecting nourishment by pickling, brew and wine making.  The present day aging innovation ventures that became out of these practices. Which produces "characteristic items" to be utilized as medications, biodegradable plastics, solvents and other modern chemicals and furnish us with amino acids, vitamins.

Track 13: Biopharmaceutical Production in Transgenic Animals

Medicate security is a noteworthy concentration of pharmaceutical microbiology. The most imperative commitment of microbiology to the pharmaceutical business is the improvement of anti-infection agents. Pathogenicmicroscopic organisms, growths and poisons delivered by microorganisms. The results of microbial digestion are all conceivable contaminants of prescriptions, however the current hereditary controls have empowered the creation of more improved medications. Antibodies are likewise a vital commitment of microbiology towards improvement of medications. Aside from medications and bio items advancement, microbiology assumes an essential part in quality control of a pharmaceutical research center. Anticipation of microbial tainting in pharmaceutical arrangements like injectables, eye drops, nasal arrangements and inward breath items.

Track 14: Development on Recombinant Protein

A prologue to the part of Pharmacokinetics and pharmacodynamics Studies the preclinical and clinical advancement in the biotech drugs, connections for peptide and protein-based medications are every now and again convoluted by their nearby collaboration with endogenous substances. Monoclonal antibodies, antisense oligonucleotides. Broad utilization of pharmacokinetic and presentation reaction ideas in all periods of medication improvement has in the past been distinguished Pharmacokinetic/pharmacodynamics as a significant element for the accomplishment of medication advancement handle.

Track 15: Biotech Companies and Market Analysis

The biotechnology division is profoundly inventive. Which has solid development direction, with its colossal development potential, will keep on playing a noteworthy part as an imaginative assembling center. The division is a standout amongst the most noteworthy parts in upgrading worldwide profile and additionally adding to the development of the economy. A Network of Technology Centers and advancement of new businesses by Small Industries. To advance development of Small and Medium Enterprises in another plan. Biopharma is the biggest part contributing around 64 for every penny of the aggregate income took after by bio services.

Track 16: Biotechnological Products

Biotechnology is frequently used to allude to hereditary designing innovation of the 21st century. However, the term is utilized for some methods for changing natural life forms for the necessities of humankind. It began with changes of local plants into enhanced sustenance edits through fake determination and hybridization. Bioengineering is the science whereupon all biotechnological applications are based. With the advancement of new methodologies and present day procedures, conventional biotechnology ventures are additionally securing new skylines empowering them to enhance the nature of their items and increment the profitability of their frameworks

Track 17: Biopharmaceutical Pharmacovigilance

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Euro Biopharama 2017 emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. 

Track 18: Bioavailability/Bioequivalence on Biopharmaceutical Products

Assume a key part in the medication improvement period for both new medication items and their nonspecific reciprocals. These studies are likewise critical in the post endorsement period within the sight of certain assembling changes. Data in the general arrangement of information that guarantee the accessibility of protected and successful pharmaceuticals to patients and experts. BA/BE studies has been resolved to have down to earth and general wellbeing esteem for pharmaceutical supporters, for administrative offices, and for patients and specialists.

Track 19: Clinical Trials on Biopharmaceutical Products

In the fields of prescription, biotechnology and pharmacology, sedate revelation is the procedure by which new candidate medications are found. Generally, medications were found through recognizing the dynamic fixing from customary cures or by fortunate revelation. Later compound libraries of manufactured little particles, characteristic items or extracts were screened in place cells or entire life forms to recognize substances that have an alluring remedial impact in a procedure known as traditional pharmacology. Since sequencing of the human genome which permitted fast cloning and amalgamation of vast amounts of cleaned proteins, it has ended up basic practice to utilize high throughput screening of expansive mixes libraries against confined organic targets which are speculated to be illness altering

Track 20: Drug Disposition & Pharmacokinetics

Assumes a focal part all through pharmaceutical innovative work. These studies help in the disclosure and determination of new compound elements, bolster wellbeing evaluation, and are basic in characterizing conditions for protected and successful use in patients. ADME contemplates give the main premise to basic judgments from circumstances where the conduct of the medication is comprehended to those where it is obscure.

Related Associations or Societies: Pharmaceutical Society of Ireland, The International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).Accreditation Council for Pharmacy Education (ACPE), Association of British Healthcare Industries (ABHI), Association of the British Pharmaceutical Industry (ABPI), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & Biopharmacy, European Association of Clinical Pharmacology and Therapeutics (EACPT), Japan Pharmaceutical Association, Japan Society of Drug Delivery System, American Association of Pharmaceutical Scientists-AAPS, The Japanese Society of Pharmacognosy, Japanese Pharmacological Society, Pharmacological Society of Taiwan, Pharmaceutical Society of Korea, Pharmaceutical Society of Australia, Parenteral Drug Association, Chinese Biopharmaceutical Association, Chinese American Biopharmaceutical Society, Japanese Society For Bioinformatics, Japan Bioindustry Association, The Society for Biotechnology Japan, Japan Society for Bioscience, Biotechnology, and Agro chemistry, The Photobiology Association of Japan, Japanese Society for Plant Cell and Molecular Biology, Japanese Society for Marine Biotechnology, Japan Pharmaceutical Manufacturers Association(JPMA), Swiss Biotech Association

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings | Pharma Biotech Conference | Biotechnology Conferences 


9th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany, World Congress on Pharmaceutical Biotechnology & Bioengineering March 25-26, 2019 Orlando, Florida, USA, 11th World Congress on Pharmacology & Therapeutics April 17-18, 2019 Montreal, Canada, 2nd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine March 20-21, 2019 New York , USA, 8th International Conference on Clinical Trials September 11-13, 2019 | Orlando, Florida, USA, World Congress on Pharmaceutical Biotechnology March 25-26, 2019 Orlando, Florida, US, Digi Pharma Connect February 27 - March 01, 2019, Austin, Texas, 17th  Annual eyeforpharma April 2019, Philadelphia.


17th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Scotland, UK, 15th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology March 18-19, 2019 Paris, France, 2 th European Biosimilars Congress April 15-16, 2019 Berlin, Germany, 16th Annual European Pharma Congress May 20-21, 2019 Zurich, Switzerland, 3rd Global Pharmaceutical Expo and Conference July 03-05, 2019, London UK, Europe’s End-to-End Pharma Procurement Event 19 - 20 March, 2019, Frankfurt, 2nd World Congress on Pharmaceutical and Chemical Sciences July 23-25, 2018, bologna, Italy

Asia Pacific:

2nd Annual Pharmaceutical Biotechnology Congress May 06-07, 2019 Tokyo, Japan, Pharmatech 2019 May 22-23 2019 Sydney, Australia, 6th World Congress on Advanced Clinical Trials and Clinical Research May 06-07, 2019 Brisbane, Australia, 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, 22nd World Congress on Biotechnology November 19-20, 2018 Bangkok, Thailand; International Biotechnology and Health Care Convention - October 5 - 6, 2018 Osaka, Japan, 11thAsia Pacific Global Summit on Healthcare May 08-09, 2019 Tokyo, Japan, 4th International Conference on Biochemistry & Molecular Biology May 10-11, 2019 Tokyo, Japan, 13th International conference on Proteomics Genomics and Bioinformatics May 10-11, 2019 Tokyo, Japan. 12th Asian Biologics and Biosimilars Congress August 20-21, 2018 Tokyo, Japan, 12thINT’L pharmaceutical Ingredients Expo June 27- 29, 2018, Tokyo, Japan, CPhI Japan 18 - 20 March 2019 Tokyo, Japan

Middle East:

6th World Congress on Drug Discovery & Toxicology April 22-23, 2019 Abu Dhabi, UAE, 12th International Conference on Pharmacoepidemiology and Clinical Research December 13-14, 2018 Abu Dhabi, UAE, 10th World Congress on Bioavailability & Bioequivalence April 08-10, 2019 Abu Dhabi, UAE, Med Lab 4 – 7 February 2019, Dubai, UAE, CPhl Middle east& Africa 3-5 September 2018 ADNEC, Abu Dhabi, UAE

Market analysis

The Global Biopharmaceutical Market is poised to grow at a CAGR of around 10.1% over the next decade to reach approximately $459.81 billion by 2025.The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the Pharma market. It’s by far the fastest-growing part of the industry. Biopharma’s current annual growth rate of more than 8% is double that of conventional Pharma, and growth is expected to continue at that rate for the foreseeable future.

It is estimated at USD 215 million for the year 2017 and is projected to reach USD 269 billion by the year 2021. The estimated CAGR during the forecast period (2017-2021) is 5.76%.

As the Japanese Pharma economy is in a state of transition towards greater openness, potential rewards for early international movers were cited as another key factor in the rapid shifts predicted in 2018.

The pharmaceutical market in Japan is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to Global Data, a recognized leader in providing business information and analytics.

Japan represents the world’s eighth biggest market for generic drugs in terms of value. Generic drugs, however, have traditionally enjoyed a relatively lower penetration in Japan compared to other developed markets such as the United States and Europe.

The Japanese government has identified growth of the country’s generic drug market as imperative to Japan’s long-term economic health

The penetration of generics has grown robustly over the past few years. The government has also made a target towards achieving a generic penetration of 60% by 2018. This is expected to create huge opportunities for both domestic and foreign generic manufacturers in Japan.

The biggest change for Pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Japanese officials proudly say some drug approvals in Japan are now faster than in both Europe and the U.S.—a marked change from the days when Japan was seen as a difficult market for foreign companies.

Related Associations or Societies: Pharmaceutical Society of IrelandThe International Society for Pharmaceutical Engineering (ISPE), European Association of Employed Community Pharmacists in Europe (EPhEU), Pharmaceutical Group of the European Union (PGEU).Accreditation Council for Pharmacy Education (ACPE), Association of British Healthcare Industries (ABHI), Association of the British Pharmaceutical Industry (ABPI), National Pharmacy Association (NPA), Dutch Society for Clinical Pharmacology & BiopharmacyEuropean Association of Clinical Pharmacology and Therapeutics (EACPT), Japan Pharmaceutical AssociationJapan Society of Drug Delivery System, American Association of Pharmaceutical Scientists-AAPS, The Japanese Society of PharmacognosyJapanese Pharmacological SocietyPharmacological Society of TaiwanPharmaceutical Society of KoreaPharmaceutical Society of Australia, Parenteral Drug AssociationChinese Biopharmaceutical AssociationChinese American Biopharmaceutical SocietyJapanese Society For BioinformaticsJapan Bioindustry AssociationThe Society for Biotechnology Japan, Japan Society for Bioscience, Biotechnology, and Agro chemistryThe Photobiology Association of JapanJapanese Society for Plant Cell and Molecular BiologyJapanese Society for Marine Biotechnology, Japan Pharmaceutical Manufacturers Association(JPMA), Swiss Biotech Association

Related Biopharmaceutics Conferences | Biopharmaceutics Meetings | Pharma Biotech Conference | Biotechnology Conferences 


9th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry February 25- 26, 2019 Berlin, Germany, World Congress on Pharmaceutical Biotechnology & Bioengineering March 25-26, 2019 Orlando, Florida, USA, 11th World Congress on Pharmacology & Therapeutics April 17-18, 2019 Montreal, Canada, 2nd International Conference and Exhibition on Pharmaceutical Nanotechnology and Nanomedicine March 20-21, 2019 New York , USA, 8th International Conference on Clinical Trials September 11-13, 2019 | Orlando, Florida, USA, World Congress on Pharmaceutical Biotechnology March 25-26, 2019 Orlando, Florida, US, Digi Pharma Connect February 27 - March 01, 2019, Austin, Texas, 17th  Annual eyeforpharma April 2019, Philadelphia.


17th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 18-20, 2019 Scotland, UK, 15th International Conference and Exhibition on Nanomedicine and Pharmaceutical NanotechnologyMarch 18-19, 2019 Paris, France, 2 th European Biosimilars Congress April 15-16, 2019 Berlin, Germany, 16th Annual European Pharma Congress May 20-21, 2019 Zurich, Switzerland, 3rd Global Pharmaceutical Expo and ConferenceJuly 03-05, 2019, London UK, Europe’s End-to-End Pharma Procurement Event 19 - 20 March, 2019, Frankfurt, 2ndWorld Congress on Pharmaceutical and Chemical Sciences July 23-25, 2018, bologna, Italy

Asia Pacific:

2nd Annual Pharmaceutical Biotechnology Congress May 06-07, 2019 Tokyo, Japan, Pharmatech 2019 May 22-23 2019 Sydney, Australia, 6th World Congress on Advanced Clinical Trials and Clinical Research May 06-07, 2019 Brisbane, Australia, 8th World Congress on Plant Genomics and Agricultural Sciences August 20-21, 2018 Tokyo, 22nd World Congress on Biotechnology November 19-20, 2018 Bangkok, Thailand; International Biotechnology and Health Care Convention - October 5 - 6, 2018 Osaka, Japan, 11thAsia Pacific Global Summit on Healthcare May 08-09, 2019 Tokyo, Japan, 4th International Conference on Biochemistry & Molecular Biology May 10-11, 2019 Tokyo, Japan, 13thInternational conference on Proteomics Genomics and Bioinformatics May 10-11, 2019 Tokyo, Japan. 12th Asian Biologics and Biosimilars Congress August 20-21, 2018 Tokyo, Japan, 12thINT’L pharmaceutical Ingredients ExpoJune 27- 29, 2018, Tokyo, Japan, CPhI Japan 18 - 20 March 2019 Tokyo, Japan

Middle East:

6th World Congress on Drug Discovery & Toxicology April 22-23, 2019 Abu Dhabi, UAE, 12th International Conference on Pharmacoepidemiology and Clinical Research December 13-14, 2018 Abu Dhabi, UAE, 10th World Congress on Bioavailability & Bioequivalence April 08-10, 2019 Abu Dhabi, UAE, Med Lab 4 – 7 February 2019, Dubai, UAE, CPhl Middle east& Africa 3-5 September 2018 ADNEC, Abu Dhabi, UAE

Past Conference Report

Pharma Biotech Congress 2018

Annual Pharmaceutical Biotechnology Congress was hosted by the Conference Series llc LTD in Singapore during May 16-17, 2018 with the theme “Latest Research and Development Trends for Optimum Solutions in the Field”.

The Conference marked its start by an opening ceremony which included introduction by the Honorable Guests and the Members of Keynote Forum. All the speakers have extended their contribution in the form of highly informative presentations to lead the conference to the ladder of success.

Conference Series llc LTD extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.

We would like to specially thank the following people who laid the foundation for the event’s success

Keynote Speakers:

  • Jiong-Wei Wang, National University of Singapore, Singapore
  • Monika Mehta, National University of Singapore, Singapore


  • Eshu Middha, National University of Singapore, Singapore

The highlights of the meeting were the peerless lectures from:

  • Muthu Kumara Gnanasammandhan Jayakumar, National University of Singapore, Singapore
  • Eshu Middha, National University of Singapore, Singapore
  • Kritika Khurana, IQVIA, USA
  • Neha Dikshit, Duke-NUS Medical School, Singapore, Singapore
  • More Vrunal, Shri Vithal Education and Research Institutes College of Pharmacy, India
  • Khushboo Tripathi, PES University, India
  • Kartika Sari, Warmadewa University, Indonesia
  • Maryam Hamidinia, National University of Singapore, Singapore
  • Judy Staveley, Frederick Community College, USA
  • Martin Michael Dcona, Virginia Commonwealth University, USA



  DOTMATICS, Australia

Conference Series llc LTD expresses gratitude to the Organizing Committee Members for their generous nearness, support and help towards Pharma Biotech Congress 2018

Also, other eminent personalities who supported the conference by facilitating the discussion forums. Conference Series Group also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Pharma Biotech Congress 2018, we are pleased to announce 2nd Annual Pharmaceutical Biotechnology Congress  to be held during May 06-07, 2019 in Tokyo, Japan.

For More details visit:

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 11-12, 2019

Speaker Opportunity

Supported By

Pharmaceutica Analytica Acta Journal of Pharmaceutical Care & Health Systems Journal of Biotechnology & Biomaterials International Journal of Research and Development in Pharmacy & Life Sciences

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos